How human IgGs against DNA recognize oligonucleotides and DNA
Sergey L Andreev1, Valentina N Buneva1,2, Georgy A Nevinsky1,2
1Institute of Chemical Biology and Fundamental Medicine, Novosibirsk, Russia.
Journal of Molecular Recognition : JMR
|August 26, 2016
Summary
Researchers investigated how anti-DNA antibodies recognize DNA using patient samples. The heavy chain of immunoglobulin G (IgG) binds DNA more strongly than the light chain, with interactions stabilizing at 8-9 nucleotides.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Limited understanding of anti-DNA antibody-DNA molecular recognition mechanisms.
- Anti-DNA antibodies are implicated in autoimmune diseases like multiple sclerosis.
- Previous studies lacked detailed data on nucleotide contributions to antibody affinity.
Purpose of the Study:
- To elucidate the molecular mechanisms of DNA recognition by anti-DNA antibodies.
- To determine the relative contributions of nucleotide units to IgG affinity for DNA.
- To compare DNA binding affinities of heavy and light antibody chains.
Main Methods:
- Utilized anti-DNA immunoglobulin G (IgG) from multiple sclerosis patient sera.
- Employed a stepwise increase in ligand complexity approach with single- and double-stranded oligonucleotides.
- Measured binding affinities (Kd) using various DNA and RNA oligonucleotide lengths and structures.
- Constructed thermodynamic models to describe IgG-DNA interactions.
Main Results:
- The DNA-binding site on the heavy chain exhibits significantly higher affinity for deoxynucleotide monophosphates (dNMPs) than the light chain site.
- Both heavy and light chains interact with 2-4 nucleotides, with affinity plateauing at 8-9 nucleotides.
- Ribooligonucleotides show 6- to 100-fold lower affinity compared to deoxynucleotides.
- Heavy chains show moderate affinity increase from single- to double-stranded DNA, while light chains show no change.
- Long supercoiled DNA exhibits approximately 10-fold higher affinity for both chains compared to short oligonucleotides.
Conclusions:
- The heavy chain is the primary driver of high-affinity DNA binding in these anti-DNA IgGs.
- Antibody affinity is dependent on oligonucleotide length, structure (ssDNA vs. dsDNA), and conformation.
- Thermodynamic models provide a framework for understanding the complex interactions between antibody chains and DNA.
Related Concept Videos
Antibody Structure
67.0K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
67.0K
Antibody Structure and Classes
10.0K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
10.0K
Antigens Involved in Adaptive Immunity
1.8K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.8K
Antibody Actions
3.4K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.4K
Immunoprecipitation
7.8K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
7.8K
Enzyme-Linked Immunosorbent Assay
18.3K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
18.3K


